The Mycobacterial Adjuvant Analogue TDB Attenuates Neuroinflammation Via Mincle-Independent PLC-γ1/PKC/ERK Signaling and Microglial Polarization

Overview

Journal Mol Neurobiol

Specialties Molecular Biology
Neurology

Date 2018 Jun 8

PMID 29876879

Citations 19

Authors

Mahendravarman Mohanraj

Ponarulselvam Sekar

Horng-Huei Liou

Shwu-Fen Chang

Wan-Wan Lin

Affiliations

Soon will be listed here.

Abstract

Microglial activation has long been recognized as a hallmark of neuroinflammation. Recently, the bacillus Calmette-Guerin (BCG) vaccine has been reported to exert neuroprotective effects against several neurodegenerative disorders. Trehalose-6,6'-dibehenate (TDB) is a synthetic analogue of trehalose-6,6'-dimycolate (TDM, also known as the mycobacterial cord factor) and is a new adjuvant of tuberculosis subunit vaccine currently in clinical trials. Both TDM and TDB can activate macrophages and dendritic cells through binding to C-type lectin receptor Mincle; however, its action mechanism in microglia and their relationship with neuroinflammation are still unknown. In this article, we found that TDB inhibited LPS-induced M1 microglial polarization in primary microglia and BV-2 cells. However, TDB itself had no effects on IKK, p38, and JNK activities or cytokine expression. In contrast, TDB activated ERK1/2 through PLC-γ1/PKC signaling and in turn decreased LPS-induced NF-κB nuclear translocation. Furthermore, TDB-induced AMPK activation via PLC-γ1/calcium/CaMKKβ-dependent pathway and thereby enhanced M2 gene expressions. Interestingly, knocking out Mincle did not alter the anti-inflammatory and M2 polarization effects of TDB in microglia. Conditional media from LPS-stimulated microglial cells can induce in vitro neurotoxicity, and this action was attenuated by TDB. Using a mouse neuroinflammation model, we found that TDB suppressed LPS-induced M1 microglial activation and sickness behavior, but promoted M2 microglial polarization in both WT and Mincle mice. Taken together, our results suggest that TDB can act independently of Mincle to inhibit LPS-induced inflammatory response through PLC-γ1/PKC/ERK signaling and promote microglial polarization towards M2 phenotype via PLC-γ1/calcium/CaMKKβ/AMPK pathway. Thus, TDB may be a promising therapeutic agent for the treatment of neuroinflammatory diseases.

Citing Articles

The CB2-PKC pathway is involved in esketamine-induced anti-inflammation in BV-2 microglial cells exposed to lipopolysaccharides.

Wang Y, Cao M, Zhang Y, Chen Q, Chen Z, Jia J Am J Transl Res. 2024; 16(9):4466-4478.

PMID: 39398580 PMC: 11470345. DOI: 10.62347/RRZF5229.

Interactions between CNS and immune cells in tuberculous meningitis.

Ma Q, Chen J, Kong X, Zeng Y, Chen Z, Liu H Front Immunol. 2024; 15:1326859.

PMID: 38361935 PMC: 10867975. DOI: 10.3389/fimmu.2024.1326859.

Exploring Chinese herbal medicine for ischemic stroke: insights into microglia and signaling pathways.

Zhang W, Xu H, Li C, Han B, Zhang Y Front Pharmacol. 2024; 15:1333006.

PMID: 38318134 PMC: 10838993. DOI: 10.3389/fphar.2024.1333006.

An Update on Protein Kinases as Therapeutic Targets-Part I: Protein Kinase C Activation and Its Role in Cancer and Cardiovascular Diseases.

Silnitsky S, Rubin S, Zerihun M, Qvit N Int J Mol Sci. 2023; 24(24).

PMID: 38139428 PMC: 10743896. DOI: 10.3390/ijms242417600.

Progress towards Adjuvant Development: Focus on Antiviral Therapy.

Brai A, Poggialini F, Pasqualini C, Trivisani C, Vagaggini C, Dreassi E Int J Mol Sci. 2023; 24(11).

PMID: 37298177 PMC: 10253057. DOI: 10.3390/ijms24119225.

References

Xu L, He D, Bai Y . Microglia-Mediated Inflammation and Neurodegenerative Disease. Mol Neurobiol. 2015; 53(10):6709-6715. DOI: 10.1007/s12035-015-9593-4. View

Grahame Hardie D . AMP-activated protein kinase: a key regulator of energy balance with many roles in human disease. J Intern Med. 2014; 276(6):543-59. PMC: 5705060. DOI: 10.1111/joim.12268. View

Hu X, Leak R, Shi Y, Suenaga J, Gao Y, Zheng P . Microglial and macrophage polarization—new prospects for brain repair. Nat Rev Neurol. 2014; 11(1):56-64. PMC: 4395497. DOI: 10.1038/nrneurol.2014.207. View

Xie Y, Guo H, Wang L, Xu L, Zhang X, Yu L . Human albumin attenuates excessive innate immunity via inhibition of microglial Mincle/Syk signaling in subarachnoid hemorrhage. Brain Behav Immun. 2016; 60:346-360. DOI: 10.1016/j.bbi.2016.11.004. View

Arumugam T, Manzanero S, Furtado M, Biggins P, Hsieh Y, Gelderblom M . An atypical role for the myeloid receptor Mincle in central nervous system injury. J Cereb Blood Flow Metab. 2016; 37(6):2098-2111. PMC: 5444551. DOI: 10.1177/0271678X16661201. View

Lee W, Kang J, Choi W, Zhang Q, Kim C, Choi U . Mincle-mediated translational regulation is required for strong nitric oxide production and inflammation resolution. Nat Commun. 2016; 7:11322. PMC: 4837483. DOI: 10.1038/ncomms11322. View

Amato S, Man H . Bioenergy sensing in the brain: the role of AMP-activated protein kinase in neuronal metabolism, development and neurological diseases. Cell Cycle. 2011; 10(20):3452-60. PMC: 3266175. DOI: 10.4161/cc.10.20.17953. View

Rodrigues L, Diwan V, Wheeler J . Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol. 1993; 22(6):1154-8. DOI: 10.1093/ije/22.6.1154. View

Zhao X, Zhu L, Chang Q, Jiang C, You Y, Luo T . C-type lectin receptor dectin-3 mediates trehalose 6,6'-dimycolate (TDM)-induced Mincle expression through CARD9/Bcl10/MALT1-dependent nuclear factor (NF)-κB activation. J Biol Chem. 2014; 289(43):30052-62. PMC: 4208012. DOI: 10.1074/jbc.M114.588574. View

10.

Orihuela R, McPherson C, Harry G . Microglial M1/M2 polarization and metabolic states. Br J Pharmacol. 2015; 173(4):649-65. PMC: 4742299. DOI: 10.1111/bph.13139. View

11.

Casano A, Peri F . Microglia: multitasking specialists of the brain. Dev Cell. 2015; 32(4):469-77. DOI: 10.1016/j.devcel.2015.01.018. View

12.

Zuo Z, Qi F, Yang J, Wang X, Wu Y, Wen Y . Immunization with Bacillus Calmette-Guérin (BCG) alleviates neuroinflammation and cognitive deficits in APP/PS1 mice via the recruitment of inflammation-resolving monocytes to the brain. Neurobiol Dis. 2017; 101:27-39. DOI: 10.1016/j.nbd.2017.02.001. View

13.

Agger E, Rosenkrands I, Hansen J, Brahimi K, Vandahl B, Aagaard C . Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements. PLoS One. 2008; 3(9):e3116. PMC: 2525815. DOI: 10.1371/journal.pone.0003116. View

14.

Lin Y, Huang D, Wang J, Lin Y, Hsieh S, Huang K . Syk is involved in NLRP3 inflammasome-mediated caspase-1 activation through adaptor ASC phosphorylation and enhanced oligomerization. J Leukoc Biol. 2015; 97(5):825-835. DOI: 10.1189/jlb.3HI0814-371RR. View

15.

Werninghaus K, Babiak A, Gross O, Holscher C, Dietrich H, Agger E . Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRgamma-Syk-Card9-dependent innate immune activation. J Exp Med. 2009; 206(1):89-97. PMC: 2626670. DOI: 10.1084/jem.20081445. View

16.

Glass C, Saijo K, Winner B, Marchetto M, Gage F . Mechanisms underlying inflammation in neurodegeneration. Cell. 2010; 140(6):918-34. PMC: 2873093. DOI: 10.1016/j.cell.2010.02.016. View

17.

Greco S, Mahmood S, Vahle A, Ochi A, Batel J, Deutsch M . Mincle suppresses Toll-like receptor 4 activation. J Leukoc Biol. 2016; 100(1):185-94. PMC: 6608084. DOI: 10.1189/jlb.3A0515-185R. View

18.

Kang Y, Mbonye U, DeLong C, Wada M, Smith W . Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradation. Prog Lipid Res. 2007; 46(2):108-25. PMC: 3253738. DOI: 10.1016/j.plipres.2007.01.001. View

19.

Ahmed K, Dong S, Fan M, Li J . Nuclear factor-kappaB p65 inhibits mitogen-activated protein kinase signaling pathway in radioresistant breast cancer cells. Mol Cancer Res. 2006; 4(12):945-55. DOI: 10.1158/1541-7786.MCR-06-0291. View

20.

Lin C, Shih C, Yang Y, Bien M, Lin C, Yu M . Thrombin induces inducible nitric oxide synthase expression via the MAPK, MSK1, and NF-κB signaling pathways in alveolar macrophages. Eur J Pharmacol. 2011; 672(1-3):180-7. DOI: 10.1016/j.ejphar.2011.10.005. View